Conference Scene: Immune effector mechanisms in tumor immunity

Andrew G. Sikora; Yared Hailemichael; Willem W. Overwijk

doi:10.2217/imt.11.177

Conference Scene: Immune effector mechanisms in tumor immunity

Andrew G. Sikora, Yared Hailemichael, Willem W. Overwijk

Melanoma Medical Oncology

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The 19th Annual Cancer Research Institute Cancer Immunotherapy Symposium was organized by the Cancer Research Institute in order to bring together researchers in basic, translational and clinical research, and industry representatives in order to exchange data, tools and opinions to further cancer immunotherapy. Our increasing understanding of immune mechanisms that mediate either the regression or progression of cancer is being translated into therapies that have begun to show true clinical benefit for cancer patients. The conference built on these early successes and aimed to push further into the uncharted territories of successful cancer immunotherapy.

Original language	English (US)
Pages (from-to)	141-143
Number of pages	3
Journal	Immunotherapy
Volume	4
Issue number	2
DOIs	https://doi.org/10.2217/imt.11.177
State	Published - Feb 2012

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Oncology

Access to Document

10.2217/imt.11.177

Cite this

@article{6429a6414b2b40ceb7742fdf27cb10e1,

title = "Conference Scene: Immune effector mechanisms in tumor immunity",

abstract = "The 19th Annual Cancer Research Institute Cancer Immunotherapy Symposium was organized by the Cancer Research Institute in order to bring together researchers in basic, translational and clinical research, and industry representatives in order to exchange data, tools and opinions to further cancer immunotherapy. Our increasing understanding of immune mechanisms that mediate either the regression or progression of cancer is being translated into therapies that have begun to show true clinical benefit for cancer patients. The conference built on these early successes and aimed to push further into the uncharted territories of successful cancer immunotherapy.",

author = "Sikora, {Andrew G.} and Yared Hailemichael and Overwijk, {Willem W.}",

year = "2012",

month = feb,

doi = "10.2217/imt.11.177",

language = "English (US)",

volume = "4",

pages = "141--143",

journal = "Immunotherapy",

issn = "1750-743X",

publisher = "Future Medicine Ltd.",

number = "2",

}

TY - JOUR

T1 - Conference Scene

T2 - Immune effector mechanisms in tumor immunity

AU - Sikora, Andrew G.

AU - Hailemichael, Yared

AU - Overwijk, Willem W.

PY - 2012/2

Y1 - 2012/2

N2 - The 19th Annual Cancer Research Institute Cancer Immunotherapy Symposium was organized by the Cancer Research Institute in order to bring together researchers in basic, translational and clinical research, and industry representatives in order to exchange data, tools and opinions to further cancer immunotherapy. Our increasing understanding of immune mechanisms that mediate either the regression or progression of cancer is being translated into therapies that have begun to show true clinical benefit for cancer patients. The conference built on these early successes and aimed to push further into the uncharted territories of successful cancer immunotherapy.

AB - The 19th Annual Cancer Research Institute Cancer Immunotherapy Symposium was organized by the Cancer Research Institute in order to bring together researchers in basic, translational and clinical research, and industry representatives in order to exchange data, tools and opinions to further cancer immunotherapy. Our increasing understanding of immune mechanisms that mediate either the regression or progression of cancer is being translated into therapies that have begun to show true clinical benefit for cancer patients. The conference built on these early successes and aimed to push further into the uncharted territories of successful cancer immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84857596771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857596771&partnerID=8YFLogxK

U2 - 10.2217/imt.11.177

DO - 10.2217/imt.11.177

M3 - Article

C2 - 22339456

AN - SCOPUS:84857596771

SN - 1750-743X

VL - 4

SP - 141

EP - 143

JO - Immunotherapy

JF - Immunotherapy

IS - 2

ER -

Conference Scene: Immune effector mechanisms in tumor immunity

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this